201 related articles for article (PubMed ID: 11829460)
21. [Experimental study of dually targeting gene therapy system for pituitary adenomas].
Ma CY; Lu YC; Shi JX; Ren CC; Zhu JD; Gu JR
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):262-6. PubMed ID: 15854489
[TBL] [Abstract][Full Text] [Related]
22. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
[TBL] [Abstract][Full Text] [Related]
23. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors.
Brand K; Arnold W; Bartels T; Lieber A; Kay MA; Strauss M; Dörken B
Cancer Gene Ther; 1997; 4(1):9-16. PubMed ID: 9012446
[TBL] [Abstract][Full Text] [Related]
24. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
[TBL] [Abstract][Full Text] [Related]
25. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
26. Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.
Hirai H; Satoh E; Osawa M; Inaba T; Shimazaki C; Kinoshita S; Nakagawa M; Mazda O; Imanishi J
Biochem Biophys Res Commun; 1997 Dec; 241(1):112-8. PubMed ID: 9405242
[TBL] [Abstract][Full Text] [Related]
27. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
Bilbao R; Gérolami R; Bralet MP; Qian C; Tran PL; Tennant B; Prieto J; Bréchot C
Cancer Gene Ther; 2000 May; 7(5):657-62. PubMed ID: 10830712
[TBL] [Abstract][Full Text] [Related]
28. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
[TBL] [Abstract][Full Text] [Related]
29. Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer.
Isomoto H; Ohtsuru A; Braiden V; Iwamatsu M; Miki F; Kawashita Y; Mizuta Y; Kaneda Y; Kohno S; Yamashita S
Oncol Rep; 2006 Mar; 15(3):629-35. PubMed ID: 16465423
[TBL] [Abstract][Full Text] [Related]
30. Systemic efficacy of combined suicide/cytokine gene therapy in a murine model of hepatocellular carcinoma.
Stefani AL; Barzon L; Castagliuolo I; Guido M; Pacenti M; Parolin C; Farinati F; Palù G
J Hepatol; 2005 May; 42(5):728-35. PubMed ID: 15826723
[TBL] [Abstract][Full Text] [Related]
31. Sustained release of low-dose ganciclovir from a silicone formulation prolonged the survival of rats with gliosarcomas under herpes simplex virus thymidine kinase suicide gene therapy.
Miura F; Moriuchi S; Maeda M; Sano A; Maruno M; Tsanaclis AM; Marino R; Glorioso JC; Yoshimine T
Gene Ther; 2002 Dec; 9(24):1653-8. PubMed ID: 12457278
[TBL] [Abstract][Full Text] [Related]
32. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene.
Wills KN; Huang WM; Harris MP; Machemer T; Maneval DC; Gregory RJ
Cancer Gene Ther; 1995 Sep; 2(3):191-7. PubMed ID: 8528962
[TBL] [Abstract][Full Text] [Related]
34. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells.
Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA
Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247
[TBL] [Abstract][Full Text] [Related]
35. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
36. [Tegument viral protein 22 enhanced cell-killing effect of the herpes simplex virus thymidine kinase/ganciclovir system on ovarian cancer in vivo].
Kong BH; Wang WX; Liu CS; Ma DX; Qu X
Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):195-8. PubMed ID: 12885362
[TBL] [Abstract][Full Text] [Related]
37. [Delivery of "suicide" thymidine kinase gene of herpes virus in the complex with cationic peptide into human hepatoma cells in vitro].
Ignatovich IA; Dizhe EB; Akif'ev BN; Burov SV; Boiarchuk EA; Perevozchikov AP
Tsitologiia; 2002; 44(5):455-62. PubMed ID: 14696255
[TBL] [Abstract][Full Text] [Related]
38. Therapy of head and neck squamous cell carcinoma with an oncolytic adenovirus expressing HSV-tk.
Morris JC; Wildner O
Mol Ther; 2000 Jan; 1(1):56-62. PubMed ID: 10933912
[TBL] [Abstract][Full Text] [Related]
39. Suicide gene therapy of ovarian cancer: an experimental study in rats using retroviral-mediated transfer of herpes simplex virus thymidine kinase gene.
Nagy HJ; Panis Y; Fabre M; Klatzmann D; Houssin D; Soubrane O
Anticancer Res; 2000; 20(6B):4633-8. PubMed ID: 11205314
[TBL] [Abstract][Full Text] [Related]
40. Effects of bicistronic lentiviral vector-mediated herpes simplex virus thymidine kinase/ganciclovir system on human lens epithelial cells.
Yang J; Liu TJ; Lu Y
Curr Eye Res; 2007 Jan; 32(1):33-42. PubMed ID: 17364733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]